Our story

Founded in 2012, we are a London based start-up committed to personalising medicine.
To achieve this, we've built a strong team with extensive expertise in pharmacogenetics, pharmacology, big data analytics, business strategy, the NHS and creative design.

A year after forming we were fortunate to win the IC tomorrow Digital Health Contest with our first product, an iPad based e-prescribing tool. More recently we won a place on the prestigious Wayra Acceleration Program. 

Exhibited at:

- The Dublin Web-summit
- Precision Medicine, Cold Spring Harbor Laboratory, USA
- Health 2.0 Europe

Recent press coverage: 

Meet The 13 Startups Wayra U.K. Is Accelerating In 2014, Tech Crunch
- First Databank Partners with Geneix to Enhance Personalised e-Prescribing
Opportunities and Challenges for Innovators in British Healthcare Technology, Tech City News
Elevator Pitch finalists unveiled at Dragon’s Den event, Tech City News
- Dell Entrepreneur Spotlight Series


Follow Mark on Twitter @Mark_Geneix

Follow Mark on Twitter @Mark_Geneix

Mark Bartlett, Managing Director

After finishing his postgraduate degree in Pharmacogenetics, Mark worked in the NHS and gained unique understanding into what challenges face our healthcare system and it's clinicians. During his time there he decided to use his expertise to integrate genetics into the clinical setting and save lives, so he founded Geneix. As our Managing Director Mark attends and presents at many notable events and conferences. He leads our team, guides our vision and brings invaluable industry and pharmacogenetic knowledge to the business. 


Follow Adam on Twitter @Adam_HC

Follow Adam on Twitter @Adam_HC

Dr. Adam Harman-Clarke, Director of Operations

After completing his doctorate in Theoretical Physics, Adam started his own big data consultancy where he gained skills in data interrogation and analysis. He believes that our health data holds the power to improve care and revolutionise medicine, so he co-founded Geneix.  As Director of Operations, Adam combines his extensive technical understanding, with his Prince 2 project management training, to oversee product build and lead the development team.  


Follow Morgaine on Twitter @MorgsM 

Follow Morgaine on Twitter @MorgsM 

Morgaine Matthews, Creative Director

With a masters degree in Science Communication, and 4 years experience in London's leading healthcare advertising agencies, Morgaine has key skills in user experience design, copywriting and information architecture. Her love of digital innovation and health makes her a perfect fit for Geneix. As Creative Director Morgaine manages the Geneix brand, oversees external communications, leads on design and applies her creative approach to support Sarah in business strategy.  


Andrew Jefferson, Lead Developer

Mid-way through his PhD in pharmaceutical chemical engineering Andrew was inspired to leave and set-up his own business in software design and engineering. After working for two successful startups and a year working for Apple in California - Andrew joined Geneix. If you have iOS 8 or 'Yosemite' then, chances are, you've used Andrew's code. As Lead Developer Andrew guides our technical approach and develops the software that makes Geneix extraordinary.


Follow Sarah on Twitter @SARAHZAREIAN 

Follow Sarah on Twitter @SARAHZAREIAN 

Sarah Zareian, Strategy Director

Sarah is an experienced clinical pharmacist by background and over the last few years she's worked as a healthcare management consultant for a Big 4 firm. Sarah has led teams and worked as an advisor to support organisations such as Acute NHS hospitals, CCGs and the UK Department of Health (including Board-level, middle management and clinicians) to do everything from programme management, clinical pathways design and regional clinical strategy re-design. Sarah holds a Masters in Business Administration with a focus on entrepreneurship from Warwick Business School. Sarah leads Geneix's business strategy, implementation into industry and also explores origination and partnership opportunities for the future.